Cathepsin B and cystatin C play an inflammatory role in gouty arthritis of the knee

Clinica Chimica Acta

Volumn 411, Issue 21-22, 2010, Pages 1788-1792

  Chu, Shu Chen ^a   Yang, Shun Fa ^b   Tzang, Bor Show ^b   Hsieh, Yih Shou ^b   Lue, Ko Huang ^b   Lu, Ko Hsiu ^b,c  

^a CENTRAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Cathepsin B; Cystatin C; Gout; Inflammation; Knee

Indexed keywords

CATHEPSIN B; CYSTATIN C; GELATINASE A; GELATINASE B; PLASMINOGEN ACTIVATOR INHIBITOR 1; UROKINASE; UROKINASE RECEPTOR;

ACUTE DISEASE; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE MARKER; ENZYME ACTIVITY; FEMALE; GOUT; HUMAN; JOINT EFFUSION; KNEE ARTHRITIS; MALE; NEUTROPHIL COUNT; PRIORITY JOURNAL; SYNOVIAL FLUID;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, GOUTY; BIOLOGICAL MARKERS; CATHEPSIN B; CYSTATIN C; FEMALE; HUMANS; INFLAMMATION; KNEE JOINT; MALE; MIDDLE AGED; SYNOVIAL FLUID; YOUNG ADULT;

EID: 77956487108     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2010.07.037     Document Type: Article

References (41)

1. Chu S.C., Yang S.F., Lue K.H., et al. The clinical significance of gelatinase B in gouty arthritis of the knee. Clin Chim Acta 2004, 339:77-83.
2. Dieppe P.A., Crocker P.R., Corke C.F., Doyle D.V., Huskisson E.C., Willoughby D.A. Synovial fluid crystals. Q J Med 1979, 48:533-553.
3. Lu K.H., Yang S.F., Chu S.C., et al. The significance of altered gelatinase expression in the synovium of patient with arthritic effusions. Clin Rheumatol 2004, 23:21-26.
4. Brommer E.J., Dooijewaard G., Dijkmans B.A., Breedveld F.C. Plasminogen activators in synovial fluid and plasma from patients with arthritis. Ann Rheum Dis 1992, 51:965-968.
5. Chu S.C., Yang S.F., Lue K.H., Hsieh Y.S., Hsiao T.Y., Lu K.H. Urokinase-type plasminogen activator, receptor, and inhibitor correlating with gelatinase-B (MMP-9) contribute to inflammation in gouty arthritis of the knee. J Rheumatol 2006, 33:311-317.
6. Cawston T.E. Metalloproteinase inhibitors and the prevention of connective tissue breakdown. Pharmacol Ther 1996, 70:163-182.
7. Mazzieri R., Masiero L., Zanetta L., et al. Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants. EMBO J 1997, 16:2319-2332.
8. Daci E., Udagawa N., Martin T.J., Bouillon R., Carmeliet G. The role of the plasminogen system in bone resorption in vitro. J Bone Miner Res 1999, 14:946-952.
9. Chapman H.A., Riese R.J., Shi G.P. Emerging roles for cysteine proteases in human biology. Annu Rev Physiol 1997, 59:63-88.
10. Baici A., Knopfel M. Cysteine proteinases produced by cultured rabbit V2 carcinoma cells and rabbit skin fibroblasts. Int J Cancer 1986, 38:753-761.
11. Yan S., Sameni M., Sloane B.F. Cathepsin B and human tumor progression. Biol Chem 1998, 379:113-123.
12. Huet G., Flipo R.M., Richet C., et al. Measurement of elastase and cysteine proteinases in synovial fluid of patients with rheumatoid arthritis, sero-negative spondylarthropathies, and osteoarthritis. Clin Chem 1992, 38:1694-1697.
13. Mort J.S., Recklies A.D., Poole A.R. Extracellular presence of the lysosomal proteinase cathepsin B in rheumatoid synovium and its activity at neutral pH. Arthritis Rheum 1984, 27:509-515.
14. Trabandt A., Gay R.E., Fassbender H.G., Gay S. Cathepsin B in synovial cells at the site of joint destruction in rheumatoid arthritis. Arthritis Rheum 1991, 34:1444-1451.
15. Mishiro T., Nakano S., Takahara S., et al. Relationship between cathepsin B and thrombin in rheumatoid arthritis. J Rheumatol 2004, 31:1265-1273.
16. Shlipak M.G., Katz R., Cushman M., et al. Cystatin-C and inflammatory markers in the ambulatory elderly. Am J Med 2005, 118:1416.
17. Serveau-Avesque C., Martino M.F., Herve-Grepinet V., et al. Active cathepsins B, H, K, L and S in human inflammatory bronchoalveolar lavage fluids. Biol Cell 2006, 98:15-22.
18. Perdereau C., Godat E., Maurel M.C., Hazouard E., Diot E., Lalmanach G. Cysteine cathepsins in human silicotic bronchoalveolar lavage fluids. Biochim Biophys Acta 2006, 1762:351-356.
19. Singh D., Whooley M.A., Ix J.H., Ali S., Shlipak M.G. Association of cystatin C and estimated GFR with inflammatory biomarkers: the Heart and Soul Study. Nephrol Dial Transplant 2007, 22:1087-1092.
20. Tsai H.T., Wang P.H., Tee Y.T., Lin L.Y., Hsieh Y.S., Yang S.F. Imbalanced serum concentration between cathepsin B and cystatin C in patients with pelvic inflammatory disease. Fertil Steril 2009, 91:549-555.
21. Guo M., Mathieu P.A., Linebaugh B., Sloane B.F., Reiners J.J. Phorbol ester activation of a proteolytic cascade capable of activating latent transforming growth factor-betaL a process initiated by the exocytosis of cathepsin B. J Biol Chem 2002, 277:14829-14837.
22. Miltenburg A.M., van Laar J.M., de Kuiper R., Daha M.R., Breedveld F.C. Interleukin-6 activity in paired samples of synovial fluid. Correlation of synovial fluid interleukin-6 levels with clinical and laboratory parameters of inflammation. Br J Rheumatol 1991, 30:186-189.
23. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
24. Gudewicz P.W., Gilboa N. Human urokinase-type plasminogen activator stimulates chemotaxis of human neutrophils. Biochem Biophys Res Commun 1987, 147:1176-1181.
25. Black R., Kronheim S., Sleath P., et al. The proteolytic activation of interleukin-1 beta. Agents Actions Suppl 1991, 35:85-89.
26. Newby A.C. Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. Physiol Rev 2005, 85:1-31.
27. Buttle D.J., Handley C.J., Ilic M.Z., Saklatvala J., Murata M., Barrett A.J. Inhibition of cartilage proteoglycan release by a specific inactivator of cathepsin B and an inhibitor of matrix metalloproteinases. Evidence for two converging pathways of chondrocyte-mediated proteoglycan degradation. Arthritis Rheum 1993, 36:1709-1717.
28. Eeckhout Y., Vaes G. Further studies on the activation of procollagenase, the latent precursor of bone collagenase. Effects of lysosomal cathepsin B, plasmin and kallikrein, and spontaneous activation. Biochem J 1977, 166:21-31.
29. Cunnane G., FitzGerald O., Hummel K.M., Gay R.E., Gay S., Bresnihan B. Collagenase, cathepsin B and cathepsin L gene expression in the synovial membrane of patients with early inflammatory arthritis. Rheumatology (Oxford) 1999, 38:34-42.
30. Gupta K., Shukla M., Cowland J.B., Malemud C.J., Haqqi T.M. Neutrophil gelatinase-associated lipocalin is expressed in osteoarthritis and forms a complex with matrix metalloproteinase 9. Arthritis Rheum 2007, 56:3326-3335.
31. Garnero P., Borel O., Byrjalsen I., et al. The collagenolytic activity of cathepsin K is unique among mammalian proteinases. J Biol Chem 1998, 273:32347-32352.
32. Yasuda Y., Li Z., Greenbaum D., Bogyo M., Weber E., Bromme D., et al. Cathepsin V, a novel and potent elastolytic activity expressed in activated macrophages. J Biol Chem 2004, 279:36761-36770.
33. Vincenti M.P., Clark I.M., Brinckerhoff C.E. Using inhibitors of metalloproteinases to treat arthritis. Easier said than done?. Arthritis Rheum 1994, 37:1115-1126.
34. Chu S.C., Yang S.F., Lue K.H., Hsieh Y.S., Lin Z.I., Lu K.H. Clinical significance of gelatinases in septic arthritis of native and replaced knees. Clin Orthop Relat Res 2004, 179-183.
35. Hsieh Y.S., Yang S.F., Lue K.H., Lu K.H. Clinical correlation with the PA/plasmin system in septic arthritis of the knee. Clin Orthop Relat Res 2006, 447:172-178.
36. Kobayashi H., Schmitt M., Goretzki L., et al. Cathepsin B efficiently activates the soluble and the tumor cell receptor-bound form of the proenzyme urokinase-type plasminogen activator (Pro-uPA). J Biol Chem 1991, 266:5147-5152.
37. Cunnane G., FitzGerald O., Hummel K.M., et al. Synovial tissue protease gene expression and joint erosions in early rheumatoid arthritis. Arthritis Rheum 2001, 44:1744-1753.
38. Tak P.P., Bresnihan B. The pathogenesis and prevention of joint damage in rheumatoid arthritis: advances from synovial biopsy and tissue analysis. Arthritis Rheum 2000, 43:2619-2633.
39. Barrett A.J. The possible role of neutrophil proteinases in damage to articular cartilage. Agents Actions 1978, 8:11-18.
40. Mainardi C.L. Biochemical mechanisms of articular destruction. Rheum Dis Clin North Am 1987, 13:215-233.
41. Ioannidis J.P. Why most published research findings are false. PLoS Med 2005, 2:e124.